Elated and humbled that Cellanyx’s technology made the cover of ‘The Gold Journal’ - Urology - Feb, 2019. Congratulations to the Cellanyx Team! https://t.co/aFHJCmVHqn
Huge congratulations to our @BioInnovationVC analyst Dr Zach Collins and coworkers for having their work recognized as @sciencemagazine 2018 Breakthrough of the Year!
https://t.co/N7Au9XxNfF
This Boston startup is developing technology using live cell phenotyping for the risk-stratification of #ProstateCancer@Cellanyx https://t.co/c6AFhTwPQa
Thank you Elizabeth Nance for the thoughtful editorial in Science Translational Medicine, AAAS & Science Magazine, about Cellanyx’s #artificialintelligence powered biopsy-on-a-chip technology platform for #oncology prognosis and ac…https://t.co/E79dsBBbsz https://t.co/w3WiK9Sf37
From @JFruehauf - Big congratulations for our friends at Cellanyx, founder/CEO @Cellanyx for your publication in Nature Biomedical Engineering ! Great endorsement of your platform! #prostatecancer
MassChallenge 2012 winners.
@nat…https://t.co/42dW7VBEpq https://t.co/QWXxyWixgN
From @JFruehauf - Big congratulations for our friends at Cellanyx, founder/CEO @Cellanyx for your publication in Nature Biomedical Engineering ! Great endorsement of your platform! #prostatecancer
MassChallenge 2012 winners.
@nat…https://t.co/XQhmxZrZ7K https://t.co/A1onyF7RSg
From @JFruehauf - Big congratulations for our friends at Cellanyx, founder/CEO @Cellanyx for your publication in Nature Biomedical Engineering ! Great endorsement of your platform! #prostatecancer
MassChallenge 2012 winners.
@nat…https://t.co/XQhmxZrZ7K https://t.co/A1onyF7RSg
📣Shout out to @EricTopol! #5 on Disruptor Daily's list of the Top 25 BioTech Influencers to Watch on Twitter! via @DisruptorDaily https://t.co/rPEJHbZ8kJ
Big congratulations for our friends at @Cellanyx, founder/CEO @AshokChander for your publication in Nature Biomedical Engineering ! Great endorsement of your platform! #prostatecancer@MassChallenge 2012 winners.
https://t.co/mOZK8oBgl6
This technology, described in a study published today, can predict adverse pathologies in #prostatecancer and #breastcancer such as lymph node positivity and lymph vascular invasion, its developer @Cellanyx says
https://t.co/UbzHx2RCGU
For #cancer, we've been stuck on assessing dead tissue blocks.
Now it's time for machine vision of live cells #AI (w/ single cell resolution)
https://t.co/vcrxMAtKnl @NatBME
Encouraging results in prostate and breast cancer for prognosis
by @AshokChander@Cellanyx & colleagues